Publications by authors named "Aaron D Greenblatt"

Claim this Profile
B
Bridging the gap: Post-release outcome evaluation of the first jail-based telemedicine buprenorphine program.
Annabelle M Belcher, Hannah Smith, Christopher Welsh, Heather Fitzsimons, Angel Dalverny, Aaron D Greenblatt

Drug Alcohol Depend· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Ketamine to enhance methadone treatment retention in patients with opioid use disorder and co-morbid depression.
Peter Manza, Annabelle M Belcher, Heather Fitzsimons, Max Spaderna, Aaron D Greenblatt

Am J Drug Alcohol Abuse· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
"
"HEAL together": a randomized, hybrid type 1 effectiveness-implementation trial protocol of a peer-delivered behavioral activation intervention to improve methadone treatment retention.
Jessica F Magidson, Valerie D Bradley, Jessica S Anane, Mary B Kleinman, Julia W Felton, Aaron D Greenblatt

Front Public Health· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
"
"It's more than just the act of not using. It's a feeling of finally completing something.": Person-centered definitions of successful treatment outcomes from patients and staff at a methadone treatment program in Baltimore City.
Valerie D Bradley, Mary B Kleinman, Morgan S Anvari, Tolulope M Abidogun, C J Seitz-Brown, Aaron D Greenblatt

J Subst Use Addict Treat· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reduction in substance use stigma following a peer-recovery specialist behavioral activation intervention.
Mary B Kleinman, Morgan S Anvari, Julia W Felton, Valerie D Bradley, Annabelle M Belcher, Aaron D Greenblatt

Int J Drug Policy· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Psychosocial challenges affecting patient-defined medication for opioid use disorder treatment outcomes in a low-income, underserved population: Application of the social-ecological framework.
Mary B Kleinman, Morgan S Anvari, C J Seitz-Brown, Valerie D Bradley, Hannah Tralka, Aaron D Greenblatt

J Subst Use Addict Treat· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of Conditioned Open-label Placebo With Methadone in Treatment of Opioid Use Disorder: A Randomized Clinical Trial.
Annabelle M Belcher, Thomas O Cole, Ebonie Massey, Amy S Billing, Michael Wagner, Aaron D Greenblatt

JAMA Netw Open· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
"
"Sometimes you have to take the person and show them how": adapting behavioral activation for peer recovery specialist-delivery to improve methadone treatment retention.
Mary B Kleinman, Morgan S Anvari, Valerie D Bradley, Julia W Felton, Annabelle M Belcher, Aaron D Greenblatt

Subst Abuse Treat Prev Policy· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Race-based differences in drug use prior to onset of opioid use disorder.
Sasha Deutsch-Link, Annabelle M Belcher, Ebonie Massey, Thomas O Cole, Michael A Wagner, Aaron D Greenblatt

J Ethn Subst Abuse· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Harm reduction behaviors are associated with carrying naloxone among patients on methadone treatment.
Zofia Kozak, Daniel Ciccarone, Johannes Thrul, Thomas O Cole, Alexander L Pappas, Aaron D Greenblatt

Harm Reduct J· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient experiences of COVID-19-induced changes to methadone treatment in a large community-based opioid treatment program in Baltimore.
Tolulope M Abidogun, Thomas O Cole, Ebonie Massey, Mary Kleinman, Aaron D Greenblatt

J Subst Use Addict Treat· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peer recovery specialist-delivered, behavioral activation intervention to improve retention in methadone treatment: Results from an open-label, Type 1 hybrid effectiveness-implementation pilot trial.
Jessica F Magidson, Mary B Kleinman, Valerie Bradley, Morgan S Anvari, Tolulope M Abidogun, Aaron D Greenblatt

Int J Drug Policy· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Psilocybin use patterns and perception of risk among a cohort of Black individuals with Opioid Use Disorder.
John M Clifton, Annabelle M Belcher, Aaron D Greenblatt, Christopher M Welsh, Thomas O Cole

J Psychedelic Stud· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Poor Sleep Quality and Other Risk Factors for Unemployment Among Patients on Opioid Agonist Treatment.
Margo Huffman, Marianne Cloeren, Orrin D Ware, Jodi J Frey, Aaron D Greenblatt

Subst Abuse· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient Satisfaction With Medications for Opioid Use Disorder Treatment via Telemedicine: Brief Literature Review and Development of a New Assessment.
Thomas O Cole, Darlene Robinson, Andrea Kelley-Freeman, Devang Gandhi, Aaron D Greenblatt

Front Public Health· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes for patients receiving telemedicine-delivered medication-based treatment for Opioid Use Disorder: A retrospective chart review.
Eric Weintraub, Aaron D Greenblatt, Joy Chang, Christopher J Welsh, Alexandra P Berthiaume

Heroin Addict Relat Clin Probl· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overdue for an Overhaul: How Opioid Treatment Programs Can Learn From COVID-19.
Aaron D Greenblatt, Jessica F Magidson, Annabelle M Belcher, Devang Gandhi, Eric Weintraub

Mayo Clin Proc· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Open-label dose-extending placebos for opioid use disorder: a protocol for a randomised controlled clinical trial with methadone treatment.
Annabelle M Belcher, Thomas O Cole, Aaron D Greenblatt, Stephen W Hoag, David H Epstein

BMJ Open· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Opioid-galanin receptor heteromers mediate the dopaminergic effects of opioids.
Ning-Sheng Cai, César Quiroz, Jordi Bonaventura, Alessandro Bonifazi, Thomas O Cole, Aaron D Greenblatt

J Clin Invest· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Primary Care for Persons Who Inject Drugs.
Adam J Visconti, Jarrett Sell, Aaron David Greenblatt

Am Fam Physician· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expanding access to buprenorphine treatment in rural areas with the use of telemedicine.
Eric Weintraub, Aaron David Greenblatt, Joy Chang, Seth Himelhoch, Christopher Welsh

Am J Addict· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis